Blauvelt, A. ., Conrad, C. ., Costanzo, A. ., van de Kerkhof, P. ., Han, G. ., Langley, R. G. ., Davis, L. ., Hoepken, B. ., Wiegratz, S. ., & Puig, L. . (2024). Bimekizumab Continuous Maintenance of Eesponse at Every Visit Through Two Years in Patients with Moderate to Severe Plaque Psoriasis: Post-hoc Results from Five Phase 3/3b Trials. SKIN The Journal of Cutaneous Medicine, 8(1), s303. https://doi.org/10.25251/skin.8.supp.303